These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23242291)

  • 1. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Lundkvist J
    Am Heart J; 2005 Feb; 149(2):298-303. PubMed ID: 15846268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
    Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
    Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
    Solomon R
    Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
    Hiremath S; Akbari A; Wells GA; Chow BJW
    Int Urol Nephrol; 2018 Aug; 50(8):1477-1482. PubMed ID: 29687326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
    Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
    Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
    Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
    Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
    Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
    Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
    N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
    Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
    Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
    Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
    Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
    Ludwig U; Connemann J; Keller F
    Clin Exp Nephrol; 2013 Dec; 17(6):779-82. PubMed ID: 23345070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.